Search Results - "de Santo, Carmela"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Molecular basis and current strategies of therapeutic arginine depletion for cancer by Fultang, Livingstone, Vardon, Ashley, De Santo, Carmela, Mussai, Francis

    Published in International journal of cancer (01-08-2016)
    “…Renewed interest in the use of therapeutic enzymes combined with an improved knowledge of cancer cell metabolism, has led to the translation of several…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A by Cerundolo, Vincenzo, De Santo, Carmela, Arscott, Ramon, Booth, Sarah, Karydis, Ioannis, Jones, Margaret, Asher, Ruth, Salio, Mariolina, Middleton, Mark

    Published in Nature immunology (01-11-2010)
    “…How neutrophils differentiate into anti-inflammatory or proinflammatory effector cells is unclear. Cerundolo and colleagues now show that systemic serum…”
    Get full text
    Journal Article
  7. 7

    Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment by Mussai, Francis, De Santo, Carmela, Abu-Dayyeh, Issa, Booth, Sarah, Quek, Lynn, McEwen-Smith, Rosanna M., Qureshi, Amrana, Dazzi, Francesco, Vyas, Paresh, Cerundolo, Vincenzo

    Published in Blood (01-08-2013)
    “…Acute myeloid leukemia (AML) is the most common acute leukemia in adults and the second most common frequent leukemia of childhood. Patients may present with…”
    Get full text
    Journal Article
  8. 8

    Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target by Mussai, Francis, Egan, Sharon, Higginbotham-Jones, Joseph, Perry, Tracey, Beggs, Andrew, Odintsova, Elena, Loke, Justin, Pratt, Guy, U, Kin Pong, Lo, Anthony, Ng, Margaret, Kearns, Pamela, Cheng, Paul, De Santo, Carmela

    Published in Blood (09-04-2015)
    “…Acute myeloid leukemia (AML) is one of the most common acute leukemias in adults and children, yet significant numbers of patients relapse and die of disease…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma by De Santo, Carmela, Cheng, Paul, Beggs, Andrew, Egan, Sharon, Bessudo, Alberto, Mussai, Francis

    Published in Journal of hematology and oncology (18-05-2018)
    “…Metastatic melanoma is an aggressive skin cancer with a poor prognosis. Current treatment strategies for high-stage melanoma are based around the use of…”
    Get full text
    Journal Article
  11. 11

    Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells by Collins, Paul J., Fox, Christopher P., George, Lindsay, Pearce, Hayden, Ryan, Gordon, De Santo, Carmela, Mussai, Frances, Lewis, David, Long, Heather, Shannon-Lowe, Claire

    Published in Blood (14-01-2021)
    “…Chronic active Epstein-Barr virus (CAEBV) typically presents as persistent infectious mononucleosis-like disease and/or hemophagocytic lymphohistocytosis…”
    Get full text
    Journal Article
  12. 12

    Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells by Gallina, Giovanna, Dolcetti, Luigi, Serafini, Paolo, De Santo, Carmela, Marigo, Ilaria, Colombo, Mario P, Basso, Giuseppe, Brombacher, Frank, Borrello, Ivan, Zanovello, Paola, Bicciato, Silvio, Bronte, Vincenzo

    Published in The Journal of clinical investigation (01-10-2006)
    “…Active suppression of tumor-specific T lymphocytes can limit the efficacy of immune surveillance and immunotherapy. While tumor-recruited CD11b+ myeloid cells…”
    Get full text
    Journal Article
  13. 13

    Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies by Fultang, Livingstone, Gneo, Luciana, De Santo, Carmela, Mussai, Francis J.

    Published in Frontiers in oncology (20-05-2021)
    “…Tumor cells require a higher supply of nutrients for growth and proliferation than normal cells. It is well established that metabolic reprograming in cancers…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy by Bokori-Brown, Monika, Metz, Jeremy, Petrov, Peter G, Mussai, Francis, De Santo, Carmela, Smart, Neil J, Saunders, Sarah, Knight, Bridget, Pastan, Ira, Titball, Richard W, Winlove, C Peter

    Published in Frontiers in oncology (27-11-2018)
    “…Acute Lymphoblastic Leukemia (ALL) remains the most frequent cause of cancer-related mortality in children and novel therapies are needed for the treatment of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer by Gneo, Luciana, Rizkalla, Nagy, Hejmadi, Rahul, Mussai, Francis, de Santo, Carmela, Middleton, Gary

    Published in Cancer Immunology, Immunotherapy (01-07-2022)
    “…Background Monocytic myeloid-derived suppressor cells (M-MDSCs) are significantly expanded in the blood of colorectal cancer (CRC) patients. However, their…”
    Get full text
    Journal Article
  20. 20

    Targeting the arginine metabolic brake enhances immunotherapy for leukaemia by Mussai, Francis, Wheat, Rachel, Sarrou, Evgenia, Booth, Sarah, Stavrou, Victoria, Fultang, Livingstone, Perry, Tracey, Kearns, Pamela, Cheng, Paul, Keeshan, Karen, Craddock, Charles, De Santo, Carmela

    Published in International journal of cancer (15-10-2019)
    “…Therapeutic approaches which aim to target Acute Myeloid Leukaemia through enhancement of patients’ immune responses have demonstrated limited efficacy to…”
    Get full text
    Journal Article